HomeCompareCRWRF vs NOBL

CRWRF vs NOBL: Dividend Comparison 2026

CRWRF yields 1.84% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRWRF wins by $2.1K in total portfolio value· pulled ahead in Year 2
10 years
CRWRF
CRWRF
● Live price
1.84%
Share price
$24.20
Annual div
$0.44
5Y div CAGR
12%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.9K
Annual income
$702.06
Full CRWRF calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — CRWRF vs NOBL

📍 CRWRF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRWRFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRWRF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRWRF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRWRF
Annual income on $10K today (after 15% tax)
$156.23/yr
After 10yr DRIP, annual income (after tax)
$596.75/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, CRWRF beats the other by $387.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRWRF + NOBL for your $10,000?

CRWRF: 50%NOBL: 50%
100% NOBL50/50100% CRWRF
Portfolio after 10yr
$23.9K
Annual income
$474.12/yr
Blended yield
1.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRWRF buys
0
NOBL buys
0
No recent congressional trades found for CRWRF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRWRFNOBL
Forward yield1.84%2.14%
Annual dividend / share$0.44$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR12%0%
Portfolio after 10y$24.9K$22.8K
Annual income after 10y$702.06$246.19
Total dividends collected$4.1K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CRWRF vs NOBL ($10,000, DRIP)

YearCRWRF PortfolioCRWRF Income/yrNOBL PortfolioNOBL Income/yrGap
1$10,906$205.86$10,914$214.34$8.00NOBL
2← crossover$11,904$235.00$11,897$218.63+$7.00CRWRF
3$13,006$268.50$12,952$222.72+$54.00CRWRF
4$14,224$307.05$14,086$226.62+$138.00CRWRF
5$15,571$351.49$15,302$230.33+$269.00CRWRF
6$17,063$402.76$16,607$233.85+$456.00CRWRF
7$18,720$462.00$18,007$237.18+$713.00CRWRF
8$20,561$530.53$19,508$240.35+$1.1KCRWRF
9$22,610$609.93$21,116$243.35+$1.5KCRWRF
10$24,895$702.06$22,841$246.19+$2.1KCRWRF

CRWRF vs NOBL: Complete Analysis 2026

CRWRFStock

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers InSight Denials to analyze, track, trend, and report on denial data; Trisus Healthcare Intelligence, a solution that provides insights into resource consumption on the patient level; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentrex 330; Referral Verification System; and Sentry Core, a solution that simplifies the complexities of pharmacy procurement, utilization, and compliances. Further, it offers appeal and professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Full CRWRF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this CRWRF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRWRF vs SCHDCRWRF vs JEPICRWRF vs OCRWRF vs KOCRWRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.